| Sample conc.( μg) |
Viability |
| HepG-2 cell line |
HCT-116 cell line |
| doxorubicin |
Au(III)complex |
doxorubicin |
Au(III) complex |
| 50 |
4.91 |
4.92 |
6.82 |
7.32 |
| 25 |
8.87 |
8.79 |
8.89 |
12.64 |
| 12.5 |
14.83 |
17.98 |
14.83 |
23.18 |
| 6.25 |
16.16 |
24.17 |
16.16 |
36.57 |
| 3.125 |
25.28 |
42.28 |
22.28 |
51.34 |
| 1.56 |
34.64 |
76.91 |
34.64 |
80.86 |
| 0.78 |
45.79 |
87.65 |
45.78 |
91.38 |
| 0.39 |
51.08 |
91.18 |
51.28 |
97.21 |
| 0 |
100 |
100 |
100 |
100 |
| IC50 |
0.467 µg |
2.77 µg |
0.471 µg |
3.41 µg |
|
